| Product Name | Relugolix - API |
| Product Code | DA-R138-a |
| Chemical name | Relugolix |
| Synonyms | 1-(4-{1-[(2,6-Difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1H,2H,3H,4H-thieno[2,3-d]pyrimidin-6-yl}phenyl)-3-methoxyurea; N-[4-[1-[(2,6-Difluorophenyl)methyl]-5-[(dimethylamino)methyl]-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-N'-methoxyurea;Orgovyx; Relumina; RVT 601; TAK 385; |
| Impurity | NA |
| CAS Number | 737789-87-6 |
| Alternate CAS # | NA |
| Molecular form | C29H27F2N7O5S |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 623.64 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | impurities,metabolites,pharmaceutical standards,intermediates,fine chemicals |
| Boiling Point | NA |
| Applications | Relugolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist used in the treatment of several hormone-responsive conditions. the symptomatic treatment of uterine fibroids.the treatment of advanced prostate cancer.9,10 Relugolix has also been studied in the symptomatic treatment of endometriosis. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
